ClinicalTrials.govpublic full text
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
b-cell non-hodgkin's lymphoma, cd19, car-t, relapsed/refractory, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 895353
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.